Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Shattuck Labs, a protein-engineering firm founded in 2016, has raised $118 million in series B financing to support clinical trials of its fusion protein therapies for cancer. Shattuck creates bifunctional protein therapies. One end of the engineered protein includes an immune checkpoint receptor, which takes the brakes off the immune system. The other end includes a protein that binds to tumor necrosis factor, to hit the gas on the immune system. Shattuck is working with Takeda Pharmaceutical to test the idea in the clinic.
This article has been sent to the following recipient: